Dow Hits Record Close for 11th Consecutive Session: Today’s Research Reports on Cempra and Universal Display

NEW YORK, NY / ACCESSWIRE / February 27, 2017 / The Dow Jones Industrial Average continued its streak of 11 consecutive record closes with a late-day rally Friday. The Dow fell by as much as 76 points, before settling to close at 20,821.76, up 0.05 percent, or 11.44 points. The S&P 500 Index gained 0.15 percent to close at 2,367.34, while the NASDAQ Composite Index gained 0.17 percent to close at 5,845.31. High yielding dividend stocks were amongst the top benefactors Friday as falling yields on government bonds sent investors flocking to stocks with high paying dividends. The S&P 500 is currently trading at price to forward earnings ratio of close to 17.8 as compared 25-year historic average of nearly 15, according to Reuters.

On Friday, the yield on the 10-year Treasury note dropped to 2.31 percent. In comparison, the S&P 500 Utilities sector spiked 4.3 percent for the week ended February 24th, its largest weekly gain since the week ended July 1st, 2016. The Utilities sector currently has a dividend yield of approximately 3.5 percent, according to FactSet.

Let’s Take a
Closer Look at Today’s Trending Tickers

Cempra’s shares soared 28.57 percent to close at $4.05 a share on Friday. The stock traded between $4.00 and $4.75 on volume of 21.61 million shares traded. The company has reported that its fusidic acid achieved its primary endpoint in a recent phase 3 study of oral fusidic acid in 716 patients with acute bacterial skin and skin structure infections (ABSSSI). Shares of Cempra have gained approximately 44.64 percent year-to-date.

“Considering complicated skin infections are one of the most rapidly growing reasons for hospitalizations and emergency department visits each year, the results with fusidic acid in this study are promising, especially for an outpatient population where there is a need for new oral drugs that are effective against MRSA,” said William O’Riordan, M.D., Chief Medical Officer of eStudySite, leaders in evaluating new therapeutic approaches for complicated skin infections.

Access Today’s Cempra Research Report Click
Here

Universal Display’s shares surged 20.09 percent to close at $81.00 a share on Friday. The stock traded between $73.40 and $82.50 on volume 4.78 million shares traded. The company reported a net income of $25.8 million, or $0.55 per diluted share, for the fourth quarter of 2016, compared to $18.1 million, or $0.39 per diluted share, for the fourth quarter of 2015. Revenues were $74.6 million for the fourth quarter of 2016, an increase of 20 percent when compared to a year ago. Analysts’ expectations had called for earnings of $0.42 a share, on revenues of $68.6 million, according to analysts surveyed by Thomson Reuters. The company projects revenue for the full year of 2017 to be in range of $230 million to $250 million, as compared total reported revenue of $198.9 for the year 2016. Shares of Universal Display have gained approximately 43.9 percent year-to-date.

Access Today’s Universal Display Research
Report Click Here

Today’s Features Includes:

Cempra Inc. (NASDAQ: CEMP)

Universal Display Corporation (NASDAQ: OLED)

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information, please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 456022

Go Top